With concerns of bioterrorism in mind, the US Food and Drug Administration has approved the first drug with an indication for the treatment of smallpox.
In 2010, the FDA mandated that 4 companies marketing long-acting β2 agonists perform trials comparing the safety of combination therapy with LABA plus an inhaled glucocorticoid vs an inhaled glucocorticoid...
Based on the results of 3 placebo-controlled studies, the FDA has approved a new drug derived from a component of the cannabis sativa plant for the treatment of 2 rare forms of epilepsy.
Following the success of 3 randomized trials and 1 open-label extension trial, the US Food and Drug Administration has approved a new sublingual tablet for the treatment of certain adults with nocturia.
...
In an effort to improve access to prevention and treatment for opioid dependence, the FDA has prioritized the approval of generic versions of medication-assisted treatment options.
